Advertisement
Alterity Therapeutics Limited (ATHE)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Follow
As of 01:48PM EST. Market open.
| Previous Close | 1.2100 |
| Open | 1.1810 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.1461 - 1.1810 |
| 52 Week Range | 1.0100 - 5.4100 |
| Volume | |
| Avg. Volume | 11,564 |
| Market Cap | 10.229M |
| Beta (5Y Monthly) | 0.68 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Alterity (ATHE) Up on Interim Data From Advance MSA Study
Alterity (ATHE) posts positive interim data from the phase II ATH434-202 study evaluating its lead candidate ATH434 for treating patients with multiple system atrophy. Stock rises.
- Zacks
Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data
Data from a preclinical study shows that treatment with Alterity's (ATHE) lead candidate improved motor performance and general function in monkeys with experimentally-induced Parkinson's disease.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.